News By Location

Physicists from the four experimental collaborations collecting data at the Relativistic Heavy Ion Collider (RHIC) -- the world's largest facility for nuclear physics research, located at the U.S. Department of Energy's Brookhaven National Laboratory -- presented their latest results and analyses at the Quark Matter 2004 meeting held in Oakland, California, January 11 – 17.

BioSurface Engineering Technologies, Inc. (BioSET), of College Park, Maryland, has obtained an exclusive worldwide license to a novel growth factor technology developed by scientists at the U.S. Department of Energy's Brookhaven National Laboratory in collaboration with BioSET researchers. The Brookhaven-BioSET team made biologically active synthetic analogs of two growth factors, including basic fibroblast growth factor for use in wound healing and radiation protection, as well as other applications.

Scientists at Brookhaven National Laboratory and their collaborators have discovered that some viruses can use the most abundant protein in the cells they are infecting to destroy the cells and allow new viruses to escape to infect others. The findings, described in the November 29, 2002, issue of the Journal of Biological Chemistry, may lead to the design of more effective antiviral remedies.

A team of scientists has grown ultrathin films made of organic molecules on the surface of liquid mercury. The results, reported in the November 15, 2002, issue of Science, reveal a series of new molecular structures that could lead to novel applications in nanotechnology.

Scientists from the U.S. Department of Energy's National Synchrotron Light Source located at Brookhaven National Laboratory have uncovered how a known cancer protein disrupts the normal function of human cells. This discovery, which may lead to the design of new anticancer drugs, is reported in the November 1, 2002, issue of the journal Cell.

Scientists at Brookhaven Lab have demonstrated that a miniature positron emission tomography (PET) scanner, known as microPET, and the chemical markers used in traditional PET scanning are sensitive enough to pick up subtle differences in neurochemistry between known genetic variants of mice. This research provides a non-invasive way to study and follow animal models for human neurological diseases, and may lead to new treatments.

Scientists working at the National Synchrotron Light Source (NSLS) at the U.S. Department of Energy's (DOE's) Brookhaven National Laboratory have unveiled the details of an important cancer protein. The new results, which are reported in the November 1 issue of Cell, shed light on how this protein triggers tumor growth, and may provide ways to design new anticancer drugs.

Scientists have developed and tested a new imaging technique that reveals the atomic structure of thin films with unprecedented resolution. For the first time, the technique has shown very precisely how the atoms of the first layers of a film rearrange under the action of the substrate on which the film is grown.

For the first time, scientists have observed the molecular details of biological cells fusing together, a fleeting event never before observed at this scale. This research, which could lead to more efficient drug delivery processes and gene therapy techniques, was performed at the National Synchrotron Light Source (NSLS) at the U.S. Department of Energy's Brookhaven National Laboratory, and Rice University.

For nearly 200 years, scientists have known that the elements molybdenum and oxygen can form various large molecules, which usually impart a unique blue color to aqueous solutions. Only recently have scientists been able to isolate these molecules, but no one was able to explain their supramolecular structure in solution, until now. The unique "blackberry" structure may represent a new, stable solute state never seen before.